ZA200900555B - Cyclic amine compound - Google Patents
Cyclic amine compoundInfo
- Publication number
- ZA200900555B ZA200900555B ZA200900555A ZA200900555A ZA200900555B ZA 200900555 B ZA200900555 B ZA 200900555B ZA 200900555 A ZA200900555 A ZA 200900555A ZA 200900555 A ZA200900555 A ZA 200900555A ZA 200900555 B ZA200900555 B ZA 200900555B
- Authority
- ZA
- South Africa
- Prior art keywords
- substitutable
- alkyl
- cycloalkyl
- heterocyclyl
- alkenyl
- Prior art date
Links
- -1 Cyclic amine compound Chemical class 0.000 title 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 7
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000003342 alkenyl group Chemical group 0.000 abstract 3
- 125000000623 heterocyclic group Chemical group 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 230000003276 anti-hypertensive effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Lubricants (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006173633 | 2006-06-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200900555B true ZA200900555B (en) | 2009-11-25 |
Family
ID=38833511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200900555A ZA200900555B (en) | 2006-06-23 | 2009-01-23 | Cyclic amine compound |
Country Status (19)
Country | Link |
---|---|
US (1) | US8158790B2 (xx) |
EP (1) | EP2036896B1 (xx) |
JP (2) | JP5231999B2 (xx) |
KR (1) | KR20090031517A (xx) |
CN (1) | CN101511799B (xx) |
AT (1) | ATE549322T1 (xx) |
AU (1) | AU2007262004B2 (xx) |
BR (1) | BRPI0713116A2 (xx) |
CA (1) | CA2656079C (xx) |
EA (1) | EA015664B1 (xx) |
ES (1) | ES2382572T3 (xx) |
HK (1) | HK1124057A1 (xx) |
IL (1) | IL196085A0 (xx) |
MX (1) | MX2008016154A (xx) |
NO (1) | NO20090343L (xx) |
NZ (1) | NZ573720A (xx) |
TW (1) | TW200808764A (xx) |
WO (1) | WO2007148774A1 (xx) |
ZA (1) | ZA200900555B (xx) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011065519A1 (ja) * | 2009-11-30 | 2011-06-03 | 第一三共株式会社 | 置換オキソピペラジン化合物 |
CN102875428B (zh) * | 2012-10-13 | 2014-02-12 | 太原理工大学 | 利用羧酸对环己基氮杂环丙烷开环的方法 |
CN102875421B (zh) * | 2012-10-13 | 2014-02-12 | 太原理工大学 | 基于对硝基苯甲酸的氮杂环丙烷化合物开环方法 |
TW202237143A (zh) | 2020-12-10 | 2022-10-01 | 南韓商Lg化學股份有限公司 | 酸(Boronic Acid)化合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY119161A (en) | 1994-04-18 | 2005-04-30 | Novartis Ag | Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities |
US6403587B1 (en) * | 1997-02-26 | 2002-06-11 | Pfizer Inc. | Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-α binding to its CCR 1 receptor |
US7582782B2 (en) * | 2003-11-26 | 2009-09-01 | Novartis Ag | Organic compounds |
BRPI0506490A (pt) | 2004-01-23 | 2007-02-13 | Speedel Experimenta Ag | compostos orgánicos |
WO2005090304A1 (en) | 2004-03-19 | 2005-09-29 | Speedel Experimenta Ag | Organic compounds |
-
2007
- 2007-06-22 NZ NZ573720A patent/NZ573720A/en not_active IP Right Cessation
- 2007-06-22 CA CA2656079A patent/CA2656079C/en not_active Expired - Fee Related
- 2007-06-22 ES ES07790408T patent/ES2382572T3/es active Active
- 2007-06-22 KR KR1020087031150A patent/KR20090031517A/ko not_active Application Discontinuation
- 2007-06-22 MX MX2008016154A patent/MX2008016154A/es active IP Right Grant
- 2007-06-22 CN CN2007800309386A patent/CN101511799B/zh not_active Expired - Fee Related
- 2007-06-22 BR BRPI0713116-0A patent/BRPI0713116A2/pt not_active IP Right Cessation
- 2007-06-22 US US12/306,281 patent/US8158790B2/en not_active Expired - Fee Related
- 2007-06-22 EP EP07790408A patent/EP2036896B1/en not_active Not-in-force
- 2007-06-22 AU AU2007262004A patent/AU2007262004B2/en not_active Ceased
- 2007-06-22 JP JP2008522524A patent/JP5231999B2/ja not_active Expired - Fee Related
- 2007-06-22 WO PCT/JP2007/062562 patent/WO2007148774A1/ja active Application Filing
- 2007-06-22 EA EA200970049A patent/EA015664B1/ru not_active IP Right Cessation
- 2007-06-22 AT AT07790408T patent/ATE549322T1/de active
- 2007-06-23 TW TW096122657A patent/TW200808764A/zh unknown
-
2008
- 2008-12-21 IL IL196085A patent/IL196085A0/en unknown
-
2009
- 2009-01-22 NO NO20090343A patent/NO20090343L/no not_active Application Discontinuation
- 2009-01-23 ZA ZA200900555A patent/ZA200900555B/xx unknown
- 2009-04-24 HK HK09103831.8A patent/HK1124057A1/xx not_active IP Right Cessation
-
2013
- 2013-01-28 JP JP2013012855A patent/JP2013100337A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
NZ573720A (en) | 2011-01-28 |
CN101511799B (zh) | 2012-05-30 |
ES2382572T3 (es) | 2012-06-11 |
AU2007262004B2 (en) | 2011-07-07 |
CA2656079C (en) | 2012-08-28 |
US8158790B2 (en) | 2012-04-17 |
ATE549322T1 (de) | 2012-03-15 |
EA015664B1 (ru) | 2011-10-31 |
HK1124057A1 (en) | 2009-07-03 |
EP2036896A1 (en) | 2009-03-18 |
EP2036896A4 (en) | 2010-12-15 |
KR20090031517A (ko) | 2009-03-26 |
US20090286807A1 (en) | 2009-11-19 |
AU2007262004A1 (en) | 2007-12-27 |
MX2008016154A (es) | 2009-01-20 |
BRPI0713116A2 (pt) | 2012-10-16 |
EP2036896B1 (en) | 2012-03-14 |
CN101511799A (zh) | 2009-08-19 |
WO2007148774A1 (ja) | 2007-12-27 |
EA200970049A1 (ru) | 2009-06-30 |
JPWO2007148774A1 (ja) | 2009-11-19 |
JP2013100337A (ja) | 2013-05-23 |
NO20090343L (no) | 2009-03-17 |
JP5231999B2 (ja) | 2013-07-10 |
IL196085A0 (en) | 2009-09-01 |
TW200808764A (en) | 2008-02-16 |
CA2656079A1 (en) | 2007-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200619191A (en) | Phenyl compounds with more than 2 substitutes | |
TW200637559A (en) | 3-propenylcefem derivative | |
TW200605883A (en) | Condensed heterocycle derivative having HCV inhibitory activity | |
BR0010690A (pt) | Composições de poliuretano-uréia contendo silìcio | |
PL1685093T3 (pl) | N-podstawiony p-mentanokarboksamid i zastosowanie N-podstawionych p-mentanokarboksamidów | |
ATE516326T1 (de) | Kautschukmischungen | |
TW200720252A (en) | Cyclic amine derivative having substituted alkyl group | |
SG164384A1 (en) | Novel heterocyclic compound or salt thereof and intermediate thereof | |
DK1265606T3 (da) | Celleadhæsionsinhibitorer | |
AU2003232229A1 (en) | Organo-functional polysiloxanes | |
CO6210825A2 (es) | Derivado de heterocicliden-n-(aril)acetamina | |
HK1124057A1 (en) | Cyclic amine compound | |
DK1706414T3 (da) | Fremgangsmåde til fluorcytidinderivater | |
AU2001269540A1 (en) | Serotonin reuptake inhibitors | |
TW200505446A (en) | Inhibitor of cox | |
PL1904469T3 (pl) | Nowe pochodne pirokatechiny | |
WO2005080368A3 (en) | Benzopyran compound useful for the treatment of arrhytmia | |
WO2004099130A3 (en) | 1,2-diarylimidazoles useful as inhibitors of cox | |
WO2010079499A3 (en) | Novel hydrazide containing taxane conjugates | |
AP2001002314A0 (en) | Substituted benzolactam compounds. | |
EP1533312A4 (en) | HETERO-BICYCLIC COMPOUNDS | |
TW200626007A (en) | Material for electroluminescent element and electroluminescent element | |
MY142362A (en) | Pharmaceutical composition for promoting angiogenesis | |
TW200743653A (en) | Polymer comprising organic silicon compound and boron compound | |
MX2007014382A (es) | Metodo para la alquinilacion asimetrica de alfa-imino-esteres. |